SEC Filing Summary
Entity discrepancy: The request identifies Chiron Real Estate Inc., but the supplied Form 10-Q is for Global Medical REIT Inc. (NYSE: GMRE). The summary below describes the filing as supplied; confirm the intended issuer before relying on it.
Business context and reporting period
Unaudited Form 10-Q for the quarter ended September 30, 2016, filed November 10, 2016. Global Medical REIT acquires healthcare facilities and leases them to healthcare operators, primarily under triple-net leases. The company completed its IPO in July 2016 and reported six property acquisitions during the first nine months of 2016.
Key financial metrics
| Metric | Three months ended September 30, 2016 | Nine months ended September 30, 2016 |
|---|---|---|
| Total revenue | $2.00 million | $5.09 million |
| Net loss | $1.98 million | $4.42 million |
| Basic and diluted loss per share | $0.11 | $0.68 |
| Net cash used in operating activities | Not provided for the quarter | $2.06 million |
- Revenue and expenses: Nine-month rental revenue was $4.99 million; other income was $93,196. Nine-month expenses totaled $9.51 million, including $2.98 million of general and administrative expense, $807,147 of related-party management fees, $1.53 million of depreciation, and $3.44 million of interest expense.
- Cash flow and liquidity: Nine-month investing cash outflow was $68.34 million, mainly reflecting property purchases; financing cash inflow was $142.56 million, primarily from the IPO and borrowing. Cash at September 30 was $81.35 million, plus $805,776 of restricted cash. Total assets were $205.79 million.
- Debt and equity: Notes payable to third-party lenders were $41.10 million gross, or $39.92 million net of unamortized discount. The $32.10 million Cantor loan bears 5.22% interest, is interest-only for five years, and matures in 2026. The company had $421,000 of related-party notes payable and $1.14 million due to related parties, net. Total liabilities were $46.08 million; stockholders’ equity was $159.71 million.
- Dividends: The company accrued a $0.20-per-share dividend, totaling $3.59 million, at quarter-end and paid it on October 11, 2016.
Material changes versus the prior comparable period
- Nine-month revenue increased to $5.09 million from $1.41 million in 2015, mainly because the portfolio expanded; the company had facilities from ten acquisitions by September 2016 versus three by September 2015. Quarterly revenue rose to $2.00 million from $487,102.
- Nine-month net loss widened to $4.42 million from $818,767. Management attributed higher expenses primarily to the larger portfolio, IPO-related and compliance costs, higher interest expense, and $830,827 of LTIP compensation expense.
- Cash increased from $9.18 million at December 31, 2015, reflecting IPO proceeds and financing. The IPO issued 15 million shares at $10 each and generated $137.36 million in net proceeds.
- The company converted $30.03 million of related-party convertible debentures into shares and repaid the remaining $10 million principal, plus accrued interest. It also repaid the Omaha loan, incurring a $301,200 early termination fee.
Outlook, risks, contingencies, and unusual items
- No quantified earnings or revenue guidance is provided. Management expects to pursue additional acquisitions, funded through cash, borrowing, equity, OP units, or other sources; completion of potential transactions is not assured.
- Subsequent to quarter-end, the company acquired five NOMS facilities for approximately $4.6 million, acquired Carson City properties for $3.975 million, and expected to close on the remaining two NOMS facilities for approximately $5.4 million. It also signed purchase agreements for facilities in Las Cruces and Ellijay. A $75 million secured credit-facility commitment was received after quarter-end.
- Key risks include tenant defaults or lease nonrenewals, tenant/operator financial condition, healthcare-sector competition and reimbursement changes, access to capital, interest rates, acquisition execution, and maintaining REIT tax qualification. Rental revenue was concentrated: in Q3, Omaha represented about 22%, Tennessee 18%, and Plano 17%.
- The company reported no material pending litigation and no known environmental matter expected to materially affect results. It stated disclosure controls were effective and reported no material change in internal control over financial reporting during the quarter.
- The filing’s cover page indicates “No” for having filed all required reports during the preceding 12 months; the reason is not explained in the supplied text. The company also states it planned to elect REIT treatment commencing with tax year 2016; qualification was not assured.
Important facts for investors to verify
- Confirm the intended issuer: the supplied filing is for Global Medical REIT Inc., not Chiron Real Estate Inc.
- Verify the filing-status checkbox marked “No” and the company’s reporting history.
- Assess tenant creditworthiness and rent concentration, especially the Omaha, Tennessee, and Plano exposures.
- Review the terms and conditions of the $75 million credit-facility commitment and subsequent acquisitions, including funding and lease terms.
- Evaluate whether operating cash flow and future financing can support dividends, debt service, and planned acquisitions; the filing reports operating cash outflow for the nine-month period.
- Review related-party management fees and the amended management agreement, including its termination-fee provisions and incentive-fee structure.